Close
ACHEMA MIDDLE EAST 2026

CDC Recommends Novavax COVID Jab To Mix With Pfizer, Moderna

The Centers for Disease Control and Prevention on October 19 advised adults in the United States to take Covid boosters from Novavax, even those who...

Rare Illness Study Will Get $38mn FDA Funding Over 4 Years

A total of $38 million has been granted by the US Food and Drug Administration (FDA) in the form of 19 new grants and...

UK Clinical Trials Have Plummeted In The Past Five Years

An industry analysis on October 20th revealed that the number of clinical trials launched annually in Britain decreased by 41% between 2017 and 2021,...

Uganda Gets Novel Antibodies, Antivirals From US For Ebola

Remdesivir from Gilead Sciences and MBP134, an experimental Ebola antibody drug from Mapp Biopharmaceutical Inc., were sent by the United States last week, ending...

Competition From Biosimilars Saves $21bn For US Healthcare

Amgen's market forecast for 2022 explains how competition has led to healthcare cost savings and predicts that a sizable proportion of biologics will compete...

FDA Explores For Ways That Help Tailored Gene Treatment

Peter Marks, a top official at the Food and Drug Administration, is not tasked with determining if the expense of the medicines his teams...

Merck And Moderna Sign $250mn Partnership For Cancer Vaccine

On October 12, 2022, Moderna revealed that Merck, also known as MSD outside of the US and Canada, had chosen to use its $250...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...